Characterizing the causal pathway for genetic variants associated with neurological phenotypes using human brain-derived proteome data
Leveraging high-dimensional molecular datasets can help us develop mechanistic insight
into associations between genetic variants and complex traits. In this study, we integrated …
into associations between genetic variants and complex traits. In this study, we integrated …
Single-cell transcriptomic analysis of Alzheimer's disease
Alzheimer's disease is a pervasive neurodegenerative disorder, the molecular complexity of
which remains poorly understood. Here, we analysed 80,660 single-nucleus transcriptomes …
which remains poorly understood. Here, we analysed 80,660 single-nucleus transcriptomes …
Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease
MR Johnson, K Shkura, SR Langley… - Nature …, 2016 - nature.com
Genetic determinants of cognition are poorly characterized, and their relationship to genes
that confer risk for neurodevelopmental disease is unclear. Here we performed a systems …
that confer risk for neurodevelopmental disease is unclear. Here we performed a systems …
Understanding Alzheimer disease at the interface between genetics and transcriptomics
J Verheijen, K Sleegers - Trends in Genetics, 2018 - cell.com
Over 25 genes are known to affect the risk of developing Alzheimer disease (AD), the most
common neurodegenerative dementia. However, mechanistic insights and improved …
common neurodegenerative dementia. However, mechanistic insights and improved …
[HTML][HTML] A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer's disease
Here, we report proteomic analyses of 129 human cortical tissues to define changes
associated with the asymptomatic and symptomatic stages of Alzheimer's disease (AD) …
associated with the asymptomatic and symptomatic stages of Alzheimer's disease (AD) …
Genome-wide association studies in Alzheimer disease
SC Waring, RN Rosenberg - Archives of neurology, 2008 - jamanetwork.com
The genetics of Alzheimer disease (AD) to date support an age-dependent dichotomous
model whereby earlier age of disease onset (< 60 years) is explained by 3 fully penetrant …
model whereby earlier age of disease onset (< 60 years) is explained by 3 fully penetrant …
Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes
J Schwartzentruber, S Cooper, JZ Liu… - Nature …, 2021 - nature.com
Genome-wide association studies have discovered numerous genomic loci associated with
Alzheimer's disease (AD); yet the causal genes and variants are incompletely identified. We …
Alzheimer's disease (AD); yet the causal genes and variants are incompletely identified. We …
Evolutionary conservation and divergence of the human brain transcriptome
WG Pembroke, CL Hartl, DH Geschwind - Genome biology, 2021 - Springer
Background Mouse models have allowed for the direct interrogation of genetic effects on
molecular, physiological, and behavioral brain phenotypes. However, it is unknown to what …
molecular, physiological, and behavioral brain phenotypes. However, it is unknown to what …
Interactome mapping suggests new mechanistic details underlying Alzheimer's disease
Recent advances toward the characterization of Alzheimer's disease (AD) have permitted
the identification of a dozen of genetic risk factors, although many more remain …
the identification of a dozen of genetic risk factors, although many more remain …
Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE
EM Wijsman, ND Pankratz, Y Choi, JH Rothstein… - PLoS …, 2011 - journals.plos.org
Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly.
The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the …
The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the …